Physician profile

Alex Judd

Surgery · Charlottesville, VA

NPI 1043773344

$923.91

in general payments reported to CMS, 2019-2025

8 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$777.62

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Atricure, INC. $200.51 2023
Davol INC. $196.38 2023-2024 Phasix Mesh, Progel Applicator Spray Tips
Integra Lifesciences Corporation $182.67 2023-2024 Integra, Integra Dermal Regeneration Template, Primatrix
Becton, Dickinson and Company $158.41 2023 Arista Ah Flexitip
Medtronic, INC. $97.01 2022
Silk Road Medical, INC. $39.65 2023 Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System
Acell, INC. $27.52 2019
Merck Sharp & Dohme LLC $21.76 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Alex Judd

$923.91

in general payments reported 2019-2025

Years
2019-2024
Top company
Atricure, INC.

https://glasscript.com/doctor/6462081/alex-judd

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.